(Preliminary schedule, may be subject to change)
Wednesday, February 3rd, 2016 |
|||
| AM | |||
| 6:00 – 6:50 6:50 – 7:00 |
Breakfast with Exhibitors Welcome Announcements |
||
| 7:00 – 7:20 | Etiology and management of late biochemical recurrence following open radical retropubic prostatectomy – Dr. Herbert Lepor | ||
| 7:20 – 7:40 | Contemporary role renal cortical neoplasm biopsy to optimize definitive management – Dr. Jaime Landman | ||
| 7:40 – 8:00 | Diagnosis and management of vesicovaginal fistula – Dr. Eric Rovner | ||
| 8:00 – 8:20 | Anti-testosterone therapy for prostate cancer patients: basic concepts & novel/emerging agents – Dr. Peter Schlegel | ||
| 8:20 – 8:40 | Break with Exhibitors | ||
| 8:40 – 9:00 | Adrenocortical carcinoma… Progresslessness – Dr. Robert G. Uzzo | ||
| 9:00 – 9:20 | Work-up and management of recurrent UTIs in the female – Dr. Eric Rovner | ||
| 9:20 – 9:40 | Management of the UPJ obstruction: a little more is less – Dr. Jaime Landman | ||
| 9:40 – 10:00 | Varicocele: Update for the practicing urologist – Dr. Peter Schlegel | ||
| 10:00 – 11:00 | How I do it Round Table: En bloc TURBT: State of the art and future perspective – Dr. Salvatore Micali Fibrin Glue Therapy for the Treatment of Hemorrhagic Cystitis – Dr. Pierluigi Bove Q/A – Additional Talks |
||
| PM | Intermission | ||
| 4:00 – 4:20 | Who killed Garfield? Doctors, hospitals and risks – Dr. Robert G. Uzzo | ||
| 4:20 – 4:40 | Pathophysiology of BPH/LUTS: insights into medical therapy of BPH – Dr. Herbert Lepor | ||
| 4:40 – 7:40 | Critique Panel Discussion | ||
| 7:40 |
Lite appetizers with exhibitors |
||
Thursday, February 4th, 2016 |
|||
| AM | |||
| 6:00 – 7:00 | Breakfast with Exhibitors | ||
| 7:00 – 7:20 | Advanced RCC: The best and the worst of times – a tale of two modalities – Dr. Robert G. Uzzo | ||
| 7:20 – 7:40 | Vasectomy: Guidelines and practical review – Dr. Peter Schlegel | ||
| 7:40 – 8:00 | What are the real benefits of robotic radical prostatectomy? – Dr. Herbert Lepor | ||
| 8:00 – 8:20 | Severe male infertility: non-obstructive Azoospermia – Dr. Peter Schlegel | ||
| 8:20 – 8:40 | Break with Exhibitors | ||
| 8:40 – 9:00 | Focal ablation of prostate cancer: is it ready for prime time? – Dr. Herbert Lepor | ||
| 9:00 – 9:20 | T2 bladder cancer: operate or radiate? – Dr. Robert G. Uzzo | ||
| 9:20 – 9:40 | Patient safety in surgery – Dr. Fernando J. Kim | ||
| 9:40 – 10:00 | Application of 3D printer technology for endourological training – Dr. Roberto Miano | ||
| 10:00 – 11:00 | How I do it Round table: Voiding dysfunction neurogenic bladder: contemporary management – Dr. Brian Flynn Data registries and the new merit-based incentive payment system – Dr. Quentin Clemens Q/A – Additional Talks |
||
| PM | Intermission | ||
| 4:00 – 4:20 | Lower urinary tract reconstruction – Dr. Joel Gelman | ||
| 4:20 – 4:40 | Tumor recurrence after nephron-sparing surgery: what to do? – Dr. Riccardo Autorino | ||
| 4:40 – 7:40 | Critique Panel Discussion | ||
| 7:40 |
Lite appetizers with exhibitors |
||
Friday, February 5th, 2016 |
||
| AM | ||
| 6:00 – 7:00 | Breakfast with Exhibitors | |
| 7:00 – 7:20 | Ablation for T1a (minus) renal cell carcinoma – Dr. Jaime Landman | |
| 7:20 – 7:40 | Testosterone Replacement in Prostate Cancer Patients – Dr. John Mulhall | |
| 7:40 – 8:00 | Overtreatment of urologic tumors: the turtle in the room – Dr. Robert G. Uzzo | |
| 8:00 – 8:20 | Diagnosis and treatment of urinary retention in females – Dr. Eric Rovner | |
| 8:20 – 8:40 | Break with Exhibitors | |
| 8:40 – 9:00 | Testosterone therapy: Where are we in 2016? – Dr. Peter Schlegel | |
| 9:00 – 9:20 | Pediatric Reconstruction – Dr. Margit Fisch | |
| 9:20 – 9:40 | Role of MR elastography in the diagnosis and focal treatment of prostate cancer – Dr. Simone Crivellaro | |
| 9:40 – 10:00 | Prostate cancer screening: What we’ve learned and where we should go – Dr. Gerald Andriole | |
| 10:00 – 11:00 | How I do it Round table: Endourology: New technology – Dr. Wilson Molina Q/A – Additional Talks |
|
| PM | Intermission | |
| 4:00 – 4:20 | The new era of “specialty” biopsies for diagnostic challenges: transperineal and MRI/Fusion – Dr. John Davis | |
| 4:20 – 4:40 | Contemporary understanding of Urologic Chronic Pelvic Pain Syndrome (UCPPS) – Dr. Quentin Clemens | |
| 4:40 – 7:40 | Critique Panel Discussion | |
| 7:40 |
Lite appetizers with Exhibitors |
|
Saturday, February 6th, 2016 |
||
| AM | ||
| 6:00 – 7:00 | Breakfast with Exhibitors | |
| 7:00 – 7:20 | Does one sling fit all… or not? Sizing up SUI in 2016 – Dr. Eric Rovner | |
| 7:20 – 7:40 | Dual access PCNL: simplifying stone management algorithm – Dr. Jaime Landman | |
| 7:40 – 8:00 | Role of MRI in management of prostate cancer – Dr. Herbert Lepor | |
| 8:00 – 8:20 | Mesh sling complications: tips and tricks – Dr. Eric Rovner | |
| 8:20 – 8:40 | Break with Exhibitors | |
| 8:40 – 9:00 | A novel 3D perspective on bladder nerve anatomy and the “Denerblate” concept – Dr. Jaime Landman | |
| 9:00 – 9:20 | Call of duty – Dr. Louis Kavoussi | |
| 9:20 – 9:40 | Bipolar energy in BPH – Dr. Wilson Molina | |
| 9:40 – 10:00 | 3D mapping biopsy and targeted focal therapy for prostate cancer – Dr. Priya Werahera | |
| 10:00 – 11:00 | How I do it: ICD 10 – Dr. Marc Painter & Robotic renal transplantation – Dr. Rajesh Ahlawat Q/A – Additional Talks |
|
| PM | Intermission | |
| 4:00 – 4:20 | Chronic prostatitis and chronic pelvic pain syndrome: facts, fictions, myths and realities – Dr. Curtis Nickel | |
| 4:20 – 4:40 | New advances in the treatment of overactive bladder – Dr. Brian Flynn | |
| 4:40 – 7:40 | Critique Panel Discussion | |
| 7:40 – 8:00 | Genito-Urinary trauma update – Dr. Jack McAninch | |
| 8:00 – 9:30 | Awards Banquet | |
Sunday, February 7th, 2016 |
||
| AM | ||
| 6:00 – 7:00 | Breakfast | |
| 7:00 – 7:20 | Surgeon’s eye tracking and robotics – Dr. Xiaoli Zhang | |
| 7:20 – 7:40 | Novel therapeutic strategies for ED – Dr. John Mulhall | |
| 7:40 – 8:00 | Recurrent bladder neck stricture: Therapeutic options – Dr. Margit Fisch | |
| 8:00 – 9:30 | Interesting Cases – Dr. Fernando J. Kim | |
| PM | Conclusion of meeting | |